封面
市场调查报告书
商品编码
1535238

ERCP及PTC设备市场:各市场区隔规模,占有率,法律规章,偿付,手术,2033年为止的预测

ERCP and PTC Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

内视镜逆行性胰胆管摄影 (ERCP) 是一种针对肝臟和胰臟引流管(包括胆管、胆囊和胰管)的内视镜和放射学联合手术。当胆管严重狭窄且难以透过内视镜观察时,或当先前的手术使内视镜进入变得困难时,经皮肝穿刺胆管造影(PTC)对于进入胆管非常有用。

ERCP 和 PTC 通常用于治疗阻塞性黄疸和控制胆漏(无论是良性还是恶性)。它也用于预防胰臟炎以及排出胆囊和胰液。这些装置主要透过两种方式放置:内视镜逆行性胰胆管摄影(ERCP)和经皮肝穿刺胆管摄影(PTC)。

本报告提供全球ERCP及PTC设备市场相关资料详细考察,提供市场上竞争情形,SWOT分析,到2033年为止的市场预测,地区,各国的趋势等资讯。

目录

已上市的ERCP及PTC设备和不断变化的竞争格局

  • 主要的产业趋势洞察
  • ERCP及PTC设备的各市场区隔整体市场收益和2015年~2033年的市场展望
  • 各市场区隔的手术总数,台数,平均销售价格,市场价值相关详细资料

世界,地区,各国洞察

  • ERCP及PTC设备市场SWOT分析
  • ERCP及PTC设备市场相关竞争动态的洞察和趋势
  • 各国医疗制度概要
  • 各国偿付政策
  • 各国医疗技术相关法规状况
简介目录
Product Code: GDME715MM

ERCP and PTC Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a combined endoscopic and radiologic procedure for the ducts draining the liver and pancreas which includes bile ducts, gallbladder, and pancreatic ducts. Percutaneous Transhepatic Cholangiography (PTC) is useful in accessing the biliary tree when a high-grade stricture precludes endoscopic visualization or when prior surgery makes endoscopic access difficult.

ERCP and PTC devices are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These devices are also used for preventing pancreatitis and to drain the gallbladder and pancreatic fluids. These devices are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed ERCP and PTC Devices and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total ERCP and PTC Devices market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for ERCP and PTC Devices market.
  • Competitive dynamics insights and trends provided for ERCP and PTC Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, ConMed Corp, Cook Medical Inc, Olympus Corp, Merit Medical Systems Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the ERCP and PTC devices market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving ERCP and PTC Devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ERCP and PTC Devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific ERCP and PTC Devices market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.